No Data
No Data
PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results
Analysts' Opinions Are Mixed on These Healthcare Stocks: Crispr Therapeutics AG (CRSP), Jazz Pharmaceuticals (JAZZ) and PTC Therapeutics (PTCT)
Citi Maintains PTC Therapeutics(PTCT.US) With Sell Rating, Raises Target Price to $45
PTC Therapeutics Price Target Raised to $45 From $32 at Citi
PTC Therapeutics, Inc.'s (NASDAQ:PTCT) Price Is Right But Growth Is Lacking
Morgan Stanley Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $67
Unlock the Full List